ArticleAnalytical and bioanalytical chemistry2026
Cross-validation of analytical methods for citrate ligand quantification on upconversion and iron oxide nanoparticles.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Making surface-functionalized nanoscale candidate reference and test materials for interlaboratory comparisons involving multi-method studies.Analytical and bioanalytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Analysis of nanomaterial (NM) surface chemistry is essential for understanding and controlling NM properties relevant for NM functionality, stability, and safety. In this work, we present a multimethod study of the quantification of the frequently used, biocompatible surface ligand citrate for lanthanide-based upconversion nanoparticles (UCNPs) and iron oxide nanoparticles (IONPs). Methods applied that address different yet correlated measurands with varying chemo-selectivity and rely on different sample preparation workflows include chemo-selective reversed-phase high-performance liquid chromatography (RP-HPLC) with photometric detection measuring liquid samples and dissolved NMs as well as non-selective thermogravimetric analysis (TGA) and chemo-selective pyrolysis-gas chromatography-mass spectrometry (PyGC-MS) analyzing dried NMs. Thereby, we demonstrate the applicability of the RP-HPLC method, recently developed for citrate quantification on IONPs, for UCNPs as another application-relevant NM class. In addition, the feasibility of PyGC-MS, emerging for material characterization at the trace level due to the consumption of very small sample amounts and minimum sample preparation, for NM ligand quantification is assessed. This method, which has not been applied before for NM surface analysis, indirectly quantifies citrate via the amount of acetone formed during citrate decomposition. For UCNPs, PyGC-MS measurements led to a good agreement with the TGA and RP-HPLC results within the respective measurement uncertainties. However, quantifying citrate on IONPs with PyGC-MS resulted in an overestimation of citrate, which is tentatively ascribed to IONP catalytic activity. Overall, our method cross-comparison underlines the importance of multimethod characterization schemes to assure a reliable and precise ligand quantification and to identify method- and NM-specific effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.